FI883589A0 - Förfarande för framställning av omättade aminosyraföreningar - Google Patents

Förfarande för framställning av omättade aminosyraföreningar

Info

Publication number
FI883589A0
FI883589A0 FI883589A FI883589A FI883589A0 FI 883589 A0 FI883589 A0 FI 883589A0 FI 883589 A FI883589 A FI 883589A FI 883589 A FI883589 A FI 883589A FI 883589 A0 FI883589 A0 FI 883589A0
Authority
FI
Finland
Prior art keywords
preparation
amino acid
acid compounds
unsaturated amino
unsaturated
Prior art date
Application number
FI883589A
Other languages
English (en)
Finnish (fi)
Other versions
FI94415B (sv
FI883589A (sv
FI94415C (sv
Inventor
Hans Allgeier
Christof Angst
Guido Bold
Rudolf Duthaler
Roland Heckendorn
Antonio Togni
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI883589A0 publication Critical patent/FI883589A0/sv
Publication of FI883589A publication Critical patent/FI883589A/sv
Publication of FI94415B publication Critical patent/FI94415B/sv
Application granted granted Critical
Publication of FI94415C publication Critical patent/FI94415C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/16Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165Esters of thiophosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/48Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof
    • C07F9/4808Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof the acid moiety containing a substituent or structure which is considered as characteristic
    • C07F9/4825Acyclic unsaturated acids or derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/302Acyclic unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI883589A 1987-08-04 1988-08-01 Förfarande för framställning av omättade aminosyraföreningar FI94415C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH298687 1987-08-04
CH298687 1987-08-04

Publications (4)

Publication Number Publication Date
FI883589A0 true FI883589A0 (sv) 1988-08-01
FI883589A FI883589A (sv) 1989-02-05
FI94415B FI94415B (sv) 1995-05-31
FI94415C FI94415C (sv) 1995-09-11

Family

ID=4246086

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883589A FI94415C (sv) 1987-08-04 1988-08-01 Förfarande för framställning av omättade aminosyraföreningar

Country Status (16)

Country Link
EP (1) EP0302826A3 (sv)
JP (2) JP2714018B2 (sv)
KR (1) KR970011164B1 (sv)
AU (1) AU605340B2 (sv)
CA (1) CA1328113C (sv)
DD (1) DD282016A5 (sv)
DK (1) DK434788A (sv)
FI (1) FI94415C (sv)
HU (1) HU202242B (sv)
IL (1) IL87246A (sv)
NO (1) NO172495C (sv)
NZ (1) NZ225649A (sv)
PH (1) PH27591A (sv)
PT (1) PT88170B (sv)
YU (1) YU150188A (sv)
ZA (1) ZA885653B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175344A (en) * 1986-02-13 1992-12-29 Ciba-Geigy Corporation Unsaturated amino acids
DE59007300D1 (de) * 1989-04-07 1994-11-03 Ciba Geigy Ag Ungesättigte Aminodicarbonsäurederivate.
ES2074153T3 (es) * 1989-09-26 1995-09-01 Ciba Geigy Ag Acidos fosfonicos, procedimiento para su obtencion y empleo como productos activos para medicamentos.
US5294734A (en) * 1989-09-26 1994-03-15 Ciba-Geigy Corp. 4-substituted 2-aminoalk-3-enoic acids
US5488140A (en) * 1989-09-26 1996-01-30 Ciba-Geigy Corporation 4-substituted 2-aminoalk-3-enoic
US7414086B2 (en) 2005-05-13 2008-08-19 Shin-Etsu Chemical Co., Ltd. Room temperature-curable organopolysiloxane compositions
CA2626435A1 (en) * 2005-10-18 2007-05-10 Centre National De La Recherche Scientifique (Cnrs) Hypophosphorous acid derivatives and their therapeutical applications
JP4952952B2 (ja) 2008-09-12 2012-06-13 信越化学工業株式会社 室温硬化性オルガノポリシロキサン組成物の製造方法
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0233154B1 (de) * 1986-02-13 1991-12-18 Ciba-Geigy Ag Ungesättigte Aminosäuren

Also Published As

Publication number Publication date
DK434788A (da) 1989-02-05
DK434788D0 (da) 1988-08-03
EP0302826A3 (de) 1991-04-03
PT88170A (pt) 1989-06-30
EP0302826A2 (de) 1989-02-08
AU2038988A (en) 1989-03-02
AU605340B2 (en) 1991-01-10
FI94415B (sv) 1995-05-31
JPH0248586A (ja) 1990-02-19
YU150188A (en) 1990-04-30
IL87246A (en) 1996-07-23
NZ225649A (en) 1991-05-28
KR970011164B1 (ko) 1997-07-08
FI883589A (sv) 1989-02-05
HUT47947A (en) 1989-04-28
KR890003786A (ko) 1989-04-18
DD282016A5 (de) 1990-08-29
ZA885653B (en) 1989-04-26
JPH1053597A (ja) 1998-02-24
IL87246A0 (en) 1989-03-31
JP2714018B2 (ja) 1998-02-16
FI94415C (sv) 1995-09-11
PT88170B (pt) 1995-03-01
NO172495C (no) 1993-07-28
HU202242B (en) 1991-02-28
NO883444D0 (no) 1988-08-03
CA1328113C (en) 1994-03-29
NO883444L (no) 1989-02-06
PH27591A (en) 1993-08-31
NO172495B (no) 1993-04-19

Similar Documents

Publication Publication Date Title
PT87754A (pt) Process for the preparation of new amino acid derivatives
RO86355A (ro) Procedeu pentru prepararea(s)-epimerului esterului acidului 7-beta-malonamida-7-alfa-meto0i-3-tetrazoliltiometil-1-detia-1-o0a-3-cefem-4-carbo0ilic
IS1667B (is) Hliðstæð aðferð við framleiðslu á meðferðarvirkumbis-aza-bísýklískum efnasamböndum
PT87153A (pt) Process for the preparation of acid ribofuranuronic derivatives
FI883997A (sv) Förfarande för framställning av terapeutiskt användbara substituerade 2-fenyl-4-kinolinkarboxylsyror
FI880467A0 (sv) Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner
FI881064A (sv) Förfarande för framställning av antiinflammatoriska eller analgetiska -aminoetylsubstituerade fenylföreningar
PT87642A (pt) Process for the preparation of dopamine-beta-hydroxylase inhibitors
PT87503A (pt) Process for the preparation of new cathecolamine by products
FI883589A0 (sv) Förfarande för framställning av omättade aminosyraföreningar
FI890723A (sv) Förfarande för framställning av kinolinkarboxylsyraderivat
PT87857A (pt) Process for the preparation of novel immunossupressant peptides
IS3589A7 (is) Aðferð við framleiðslu á efnasambandinu Indenoindoles I
PT88545A (pt) Process for the manufacture of benzimidazoline-2-oxo-1-carboxylic acid derivative compounds
PT88432A (pt) Process for the preparation of 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents
ES2022952B3 (es) Proceso para la preparacion de naftacenos
EP0206367A3 (en) Process for the preparation of unsaturated compounds
PT88431A (pt) Process for the preparation of 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents
FI93216C (sv) Analogiförfarande för framställning av terapeutiskt användbara 1,3-dioxanalkensyraderivat
DE3663520D1 (en) Process for the preparation of halogen-thiophene-2-carboxylic acids
FI91069B (sv) Förfarande för framställning av 5-C-hydroximetylaldohexosbaserade föreningar
FI882836A0 (sv) Förfarande för framställning av terapeutiskt användbar (E)-2-(p-fluorfenetyl)-3-fluorallylamin
BR8805858A (pt) Processo para preparacao de acidos c12-c40-graxos alfa-ramificado
EP0247485A3 (en) Process for the preparation of oxetan-3-carboxylic acids
EP0417543A3 (en) Process for the preparation of 3-methylquinolin-8-carboxylic acid

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed
MM Patent lapsed

Owner name: NOVARTIS AG